Filing Details
- Accession Number:
- 0001209191-17-014875
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-27 17:10:05
- Reporting Period:
- 2017-02-23
- Filing Date:
- 2017-02-27
- Accepted Time:
- 2017-02-27 17:10:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1130166 | Cyclacel Pharmaceuticals Inc. | CYCC | Pharmaceutical Preparations (2834) | 911766850 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1178579 | C Kevin Tang | 4747 Executive Drive Suite 510 San Diego CA 92121 | No | No | Yes | No | |
| 1191935 | Tang Capital Partners Lp | 4747 Executive Drive Suite 510 San Diego CA 92121 | No | No | Yes | No | |
| 1232621 | Tang Capital Management Llc | 4747 Executive Drive Suite 510 San Diego CA 92121 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-02-23 | 134,200 | $4.34 | 559,900 | No | 4 | P | Indirect | By LP |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By LP |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $4.09 to $4.50. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The securities are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin C. Tang is the sole manager of Tang Capital Management,LLC, which is the general partner of TCP. Mr. Tang disclaims beneficial ownership of the securities, except to the extent of his pecuniary interesttherein.
Billionaire Hedge Funds
